PATIENT TREATMENT PREFERENCE AS A PREDICTOR OF RESPONSE AND ATTRITION IN TREATMENT FOR CHRONIC DEPRESSION
Dana Steidtmann(Stanford University), James H. Kocsis(Cornell University), Rachel Manber(Palo Alto University), Barbara O. Rothbaum(York College of Pennsylvania), Daniel N. Klein(Stony Brook University), John C. Markowitz(New York Psychoanalytic Society and Institute), Michael E. Thase(Veterans Health Administration), Bruce A. Arnow
Cited by 80
Related Papers
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
|Biological Psychiatry|2003|3.9k
A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression
|New England Journal of Medicine|2000|1.3k
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
|Controlled Clinical Trials|2004|1.1k
Frontiers of cognitive therapy
|General Hospital Psychiatry|1997|1.1k